MedTrace Logo

Cognitive Effects of Sage in Healthy Humans

NCT03695003 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2020-03-17

No results posted yet for this study

Summary

Extracts of sage and polyphenols have separately been reported to interact with central nervous system (CNS) mechanisms relevant to cognitive performance but, to date, no trial has combined these interventions. The current study investigates the effects of this combined intervention in N=90 healthy males and females between 30-60 yrs, at 600 mg versus placebo, on cognition and mood over a 29 day period.

Conditions

  • Cognitive Change
  • Mood Change

Interventions

DIETARY_SUPPLEMENT

Cognivia

Cognivia is a trademarked sage/polyphenol combination dietary supplement from Nexira

DIETARY_SUPPLEMENT

Placebo

Placebo control capsules were prepared by Nexira also and are aesthetically identical to the Cognivia capsules

Sponsors & Collaborators

  • Northumbria University

    lead OTHER

Principal Investigators

  • Emma Wightman, Dr · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-03
Primary Completion
2019-09-24
Completion
2019-09-24

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03695003 on ClinicalTrials.gov